Abera Bioscience is active in biotechnology. The company specializes in the development of vaccines based on its own internal developed and patented platform. The technology is mainly used in the development of new vaccines where the focus is on the main areas of pneumococci and oncology. The business is located around the Nordic market. The company was founded in 2012 and is headquartered in Solna.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Avanza Pension | 10,59 | 10,59 | 2021-12-31 |
| Nordnet Pensionsförsäkring | 9,68 | 9,68 | 2021-12-31 |
| Anders Ericsson | 6,12 | 6,12 | 2022-01-20 |
| Jan-Willem De Gier | 5,16 | 5,16 | 2021-12-31 |
| Joen Luirink | 5,04 | 5,04 | 2021-12-31 |
| Magnus Linderoth | 4,97 | 4,97 | 2021-12-31 |
| John Moll | 4,90 | 4,90 | 2021-02-08 |
| Johan Källstrand | 3,51 | 3,51 | 2021-12-31 |
| Anders Wall Stiftelser | 2,77 | 2,77 | 2021-12-31 |
| Mårten Hellberg | 2,28 | 2,28 | 2021-02-08 |
2022-02-23 Bokslutskommuniké 2021